Your browser doesn't support javascript.
loading
Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system.
De la Cuadra-Grande, Alberto; Rioja-Zuazu, Jorge; Domínguez-Esteban, Mario; Torres, Esperanza; Blissett, Rob; Woodward, Emily; Oyagüez, Itziar; Fernández-Arjona, Manuel.
Affiliation
  • De la Cuadra-Grande A; Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.
  • Rioja-Zuazu J; Urology Department, Clínica Universitaria de Navarra, Navarra, Spain.
  • Domínguez-Esteban M; Urology Department, Hospital Marqués de Valdecilla, Cantabria, Spain.
  • Torres E; Health Economics & Market Access, Boston Scientific Inc, Madrid, Spain.
  • Blissett R; Health Economics & Economic Evaluation, MedTech Economics Ltd, Winchester, UK.
  • Woodward E; Health Economics & Market Access, Boston Scientific AG, Solothurn, Switzerland.
  • Oyagüez I; Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.
  • Fernández-Arjona M; Urology Department, Hospital Universitario del Henares, Madrid, Spain.
Expert Rev Pharmacoecon Outcomes Res ; 23(5): 499-510, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36897833
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Lower Urinary Tract Symptoms Type of study: Diagnostic_studies / Health_economic_evaluation / Risk_factors_studies Limits: Humans / Male Language: En Journal: Expert Rev Pharmacoecon Outcomes Res Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: España Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Lower Urinary Tract Symptoms Type of study: Diagnostic_studies / Health_economic_evaluation / Risk_factors_studies Limits: Humans / Male Language: En Journal: Expert Rev Pharmacoecon Outcomes Res Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: España Country of publication: Reino Unido